Levodopa-induced neutropenia

Parkinsonism Relat Disord. 2015 Apr;21(4):423-5. doi: 10.1016/j.parkreldis.2015.02.002. Epub 2015 Feb 11.

Authors

Christian Cordano¹, Matteo Pardini², Maria Cellerino², Angelo Schenone², Franca Marino³, Marco Cosentino³

Affiliations

¹ Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy; Department of Neurology, UCSF, San Francisco, USA. Electronic address: [email protected].
² Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy.
³ Center for Research in Medical Pharmacology, University of Insubria, Varese, Italy.

PMID: 25707301
DOI: 10.1016/j.parkreldis.2015.02.002

No abstract available

Keywords: Dopamine receptors (DR); Levodopa; Neuroimmunology; Parkinson's disease.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged, 80 and over
Antiparkinson Agents / administration & dosage
Antiparkinson Agents / adverse effects*
Humans
Levodopa / administration & dosage
Levodopa / adverse effects*
Male
Neutropenia / blood*
Neutropenia / chemically induced*

Substances

Antiparkinson Agents
Levodopa